BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasmal S, Balaji G, Kanna Reddy HR, Balasubrahmanyam D, Srinivas G, Kyasa S, Sasmal PK, Khanna I, Talwar R, Suresh J, Jadhav VP, Muzeeb S, Shashikumar D, Harinder Reddy K, Sebastian VJ, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists. Bioorg Med Chem Lett 2012;22:3157-62. [PMID: 22487182 DOI: 10.1016/j.bmcl.2012.03.050] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Motoyama M, Doan TH, Hibner-Kulicka P, Otake R, Lukarska M, Lohier JF, Ozawa K, Nanbu S, Alayrac C, Suzuki Y, Witulski B. Synthesis and Structure-Photophysics Evaluation of 2-N-Amino-quinazolines: Small Molecule Fluorophores for Solution and Solid State. Chem Asian J 2021;16:2087-99. [PMID: 34107175 DOI: 10.1002/asia.202100534] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Mohammadkhani L, Heravi MM. Microwave-Assisted Synthesis of Quinazolines and Quinazolinones: An Overview. Front Chem 2020;8:580086. [PMID: 33282829 DOI: 10.3389/fchem.2020.580086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bathula R, Mondal P, Raparla R, Satla SR. Evaluation of antitumor potential of synthesized novel 2-substituted 4-anilinoquinazolines as quinazoline-pyrrole hybrids in MCF-7 human breast cancer cell line and A-549 human lung adenocarcinoma cell lines. Futur J Pharm Sci 2020;6. [DOI: 10.1186/s43094-020-00059-5] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ghorai S, Lin Y, Xia Y, Wink DJ, Lee D. Silver-Catalyzed Annulation of Arynes with Nitriles for Synthesis of Structurally Diverse Quinazolines. Org Lett 2020;22:626-30. [DOI: 10.1021/acs.orglett.9b04395] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
5 Pathak P, Naumovich V, Grishina M, Shukla PK, Verma A, Potemkin V. Quinazoline based 1,3,5-triazine derivatives as cancer inhibitors by impeding the phosphorylated RET tyrosine kinase pathway: Design, synthesis, docking, and QSAR study. Arch Pharm (Weinheim) 2019;352:e1900053. [PMID: 31380598 DOI: 10.1002/ardp.201900053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
6 Maddali NK, Viswanath* IVK, Murthy* YLN, Bera R, Takhi M, Rao NS, Gudla V. Design, synthesis and molecular docking studies of quinazolin-4-ones linked to 1,2,3-triazol hybrids as Mycobacterium tuberculosis H37Rv inhibitors besides antimicrobial activity. Med Chem Res 2019;28:559-70. [DOI: 10.1007/s00044-019-02313-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
7 Dasari SR, Tondepu S, Vadali LR, Ganivada MN, Seelam N. Retracted: Synthesis, Molecular Properties, and Biological Evaluation of Hybrid 1,2,3‐Triazolylpolyaza Heterocyclic Compounds. J Heterocyclic Chem 2019;56:195-208. [DOI: 10.1002/jhet.3395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Devipriya D, Roopan SM. UV-light intervened synthesis of imidazo fused quinazoline and its solvatochromism, antioxidant, antifungal and luminescence properties. J Photochem Photobiol B 2019;190:42-9. [PMID: 30472613 DOI: 10.1016/j.jphotobiol.2018.11.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
9 Pourmousavi SA, Kanaani A, Fatahi HR, Ghorbani F, Ajloo D. SbCl 3 as effective catalyst for the preparation of 2,3-Dihydroquinazolin-4(1 H )-ones, spectroscopic investigation and DFT study. Journal of Physics and Chemistry of Solids 2017;106:82-93. [DOI: 10.1016/j.jpcs.2017.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sethukumar A, Anand PS, Kumar CU, Prakasam BA. Synthesis, stereochemical and biological studies of some N-cyclohexylcarbamoyl -2,6-diarylpiperidin-4-ones. Journal of Molecular Structure 2017;1130:352-62. [DOI: 10.1016/j.molstruc.2016.10.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mikulášková B, Maletínská L, Zicha J, Kuneš J. The role of food intake regulating peptides in cardiovascular regulation. Molecular and Cellular Endocrinology 2016;436:78-92. [DOI: 10.1016/j.mce.2016.07.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
12 Raghav N, Jangra S, Kumar A, Bhattacharyya S. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents. Int J Biol Macromol 2017;94:719-27. [PMID: 27780761 DOI: 10.1016/j.ijbiomac.2016.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Igawa H, Takahashi M, Kakegawa K, Kina A, Ikoma M, Aida J, Yasuma T, Kawata Y, Ashina S, Yamamoto S, Kundu M, Khamrai U, Hirabayashi H, Nakayama M, Nagisa Y, Kasai S, Maekawa T. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives. J Med Chem 2016;59:1116-39. [PMID: 26736071 DOI: 10.1021/acs.jmedchem.5b01704] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
14 Sert Y, Ucun F, El-hiti GA, Smith K, Hegazy AS. Spectroscopic Investigations and DFT Calculations on 3-(Diacetylamino)-2-ethyl- 3H -quinazolin-4-one. Journal of Spectroscopy 2016;2016:1-15. [DOI: 10.1155/2016/5396439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
15 Palaniraja J, Roopan SM, Rayalu GM. One-pot synthesis of highly functionalized pyrimido[1,2-b]indazoles via 6-endo-dig cyclization. RSC Adv 2016;6:24610-6. [DOI: 10.1039/c6ra02596j] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
16 El-Hiti GA, Smith K, Hegazy AS, Baashen M, Kariuki BM. Crystal structure of 3-amino-2-ethyl-quinazolin-4(3H)-one. Acta Crystallogr E Crystallogr Commun 2015;71:o650-1. [PMID: 26396885 DOI: 10.1107/S2056989015014450] [Reference Citation Analysis]
17 El-Hiti GA, Smith K, Hegazy AS, Alanazi SA, Kariuki BM. Crystal structure of 3-amino-2-propyl-quinazolin-4(3H)-one. Acta Crystallogr E Crystallogr Commun 2015;71:o590-1. [PMID: 26396813 DOI: 10.1107/S2056989015013134] [Reference Citation Analysis]
18 Kannappan V, Vidhya P, Sathyanarayanamoorthi V. Quantum mechanical study of solvation analysis on some nitrogen containing heterocyclic compounds. Journal of Molecular Liquids 2015;207:7-13. [DOI: 10.1016/j.molliq.2015.03.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Karuna PS, Murthy RVVR, Reddy MRP, Katari NK, Srinivas K. Tandem One Pot and Efficient Method for the Palladium-Reagent-Catalyzed Cross-Coupling of Quinazoline Thiols: Tandem One Pot and Efficient Method for the Palladium-Reagent-Catalyzed Cross-Coupling of Quinazoline Thiols. J Heterocyclic Chem 2016;53:784-8. [DOI: 10.1002/jhet.2310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
20 Ahmed MF, Belal A. Design, Synthesis, and Molecular Docking Studies of 2-(Furan-2-yl)quinazolin-4-one Derivatives as Potential Antiproliferative Agents: Quinazolin-4-one Derivatives as Potent Anticancer Agents. Arch Pharm Chem Life Sci 2015;348:487-97. [DOI: 10.1002/ardp.201400468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
21 Palaniraja J, Roopan SM. UV-light induced domino type reactions: synthesis and photophysical properties of unreported nitrogen ring junction quinazolines. RSC Adv 2015;5:37415-23. [DOI: 10.1039/c5ra00229j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
22 Wu M, Li Y, Fu X, Wang J, Zhang S, Yang L. Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method. Int J Mol Sci 2014;15:15475-502. [PMID: 25257526 DOI: 10.3390/ijms150915475] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Wang D, Gao F. Quinazoline derivatives: synthesis and bioactivities. Chem Cent J 2013;7:95. [PMID: 23731671 DOI: 10.1186/1752-153X-7-95] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
24 Macneil DJ. The role of melanin-concentrating hormone and its receptors in energy homeostasis. Front Endocrinol (Lausanne) 2013;4:49. [PMID: 23626585 DOI: 10.3389/fendo.2013.00049] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
25 Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
26 Sasmal S, Balasubrahmanyam D, Kanna Reddy HR, Balaji G, Srinivas G, Cheera S, Abbineni C, Sasmal PK, Khanna I, Sebastian V, Jadhav VP, Singh MP, Talwar R, Suresh J, Shashikumar D, Harinder Reddy K, Sihorkar V, Frimurer TM, Rist Ø, Elster L, Högberg T. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: Part 2. Bioorganic & Medicinal Chemistry Letters 2012;22:3163-7. [DOI: 10.1016/j.bmcl.2012.03.049] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]